{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:10:32Z","timestamp":1790539832891,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Methadone, a synthetic narcotic, is widely used both in adults and children for pain control and as a replacement drug in opioid use disorder to prevent craving and withdrawal. To support clinical pharmacokinetic trials in neonates, infants, and children, the authors developed and validated a novel, automated, highly sensitive liquid chromatography\u2013electrospray\u2013tandem mass spectrometry ionization (LC-ESI-MS\/MS) method for the quantification of methadone and its metabolites, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP), in samples collected as dried blood spots.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Blood was spiked with different concentrations of methadone, EDDP, and EMDP, and blood drops were applied to filter paper cards. Punches of 6.4 mm were removed from the cards, and 600 \u00b5L of protein precipitation solution (methanol\/0.2M ZnSO<jats:sub>4<\/jats:sub>, 7:3, vol\/vol) containing the internal standards (methadone-d<jats:sub>9<\/jats:sub> and EDDP-d<jats:sub>5<\/jats:sub>) at a concentration of 1 mcg\/L was added. The extracts were analyzed using LC-ESI-MS\/MS in combination with online extraction. The mass spectrometer was run in the positive multiple reaction monitoring mode, and the total run time was 3.2 minutes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>For the dried blood spots, the assay has a lower limit of quantification of 0.1 mcg\/L for methadone, EDDP, and EMDP. The range of reliable response for methadone for the ion transition m\/z = 310.2\u2192265.1 was 0.1\u2013100 mcg\/L and for the ion transition m\/z = 310.2\u2192223.1 5\u20131000 mcg\/L. For EDDP, on the range of reliable response for the ion transition, m\/z = 278.2\u2192234.3 was 0.1\u2013100 mcg\/L and for the ion transition m\/z = 278.2\u2192186.1 5\u20131000 mcg\/L. The calibration range for EMDP was 0.1\u2013100 mcg\/L. Accuracy (85%\u2013115%) and imprecision (&lt;15%) met predefined acceptance criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>This assay allows for the measurement of small volume blood samples without the need for an intravenous blood draw, and thus, it is suitable for pharmacokinetics studies and therapeutic drug monitoring in pediatric patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000674","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T08:41:02Z","timestamp":1563439262000},"page":"118-128","source":"Crossref","is-referenced-by-count":7,"title":["A Sensitive LC-MS\/MS Assay for the Quantification of Methadone and its Metabolites in Dried Blood Spots: Comparison With Plasma"],"prefix":"10.1097","volume":"42","author":[{"given":"Baharak","family":"Davari","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia F.","family":"Clavijo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"},{"name":"Department of Anesthesiology, The Children's Hospital Colorado, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Rzasa-Lynn","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Galinkin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"},{"name":"Department of Anesthesiology, The Children's Hospital Colorado, Aurora, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sempio","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Colorado, Anschutz Medical Campus; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/jat\/bku096","article-title":"Quantitation of methadone and metabolite in patients under maintenance treatment","volume":"38","author":"Diong","year":"2014","journal-title":"J Anal Toxicol."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/10826080902810251","article-title":"Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them \u201csubstitution\u201d?","volume":"44","author":"Gerra","year":"2009","journal-title":"Subst Use Misuse."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/15360288.2014.938883","article-title":"Therapeutic challenges in cancer pain management: a systematic review of methadone","volume":"28","author":"Good","year":"2014","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/ALN.0000000000000633","article-title":"Intraoperative methadone for the prevention of postoperative pain: a randomized, double-blinded clinical trial in cardiac surgical patients","volume":"122","author":"Murphy","year":"2015","journal-title":"Anesthesiology."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/pan.12385","article-title":"The pharmacokinetics of methadone and its metabolites in neonates, infants, and children","volume":"24","author":"Ward","year":"2014","journal-title":"Paediatr Anaesth."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10928-006-9018-0","article-title":"Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model","volume":"33","author":"Yang","year":"2006","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00216-012-6157-6","article-title":"A novel test using dried blood spots for the chromatographic assay of methadone","volume":"404","author":"Saracino","year":"2012","journal-title":"Anal Bioanal Chem."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/pan.12021","article-title":"The pharmacokinetics of methadone in adolescents undergoing posterior spinal fusion","volume":"23","author":"Stemland","year":"2013","journal-title":"Paediatr Anaesth."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v20n02_05","article-title":"Therapeutic drug monitoring in methadone maintenance: choosing a matrix","volume":"20","author":"Moolchan","year":"2001","journal-title":"J Addict Dis."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/PCC.0b013e3182a12611","article-title":"Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*","volume":"15","author":"Bhatt-Mehta","year":"2014","journal-title":"Pediatr Crit Care Med."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jpeds.2015.08.032","article-title":"Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study","volume":"167","author":"Wiles","year":"2015","journal-title":"J Pediatr."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/ALN.0b013e318238fec5","article-title":"Perioperative pharmacokinetics of methadone in adolescents","volume":"115","author":"Sharma","year":"2011","journal-title":"Anesthesiology."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/03602532.2016.1192642","article-title":"Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response","volume":"48","author":"Dinis-Oliveira","year":"2016","journal-title":"Drug Metab Rev."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response: impact of genetic polymorphism","volume":"12","author":"Li","year":"2008","journal-title":"Mol Diagn Ther."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1465-3362.2010.00237.x","article-title":"Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?","volume":"30","author":"Mayet","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3121\/cmr.2009.859","article-title":"Quantification of a methadone metabolite (EDDP) in urine: assessment of compliance","volume":"7","author":"Larson","year":"2009","journal-title":"Clin Med Res."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpba.2016.06.026","article-title":"Clinical feasibility of dried blood spots: analytics, validation, and applications","volume":"130","author":"Enderle","year":"2016","journal-title":"J Pharm Biomed Anal."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00216-011-5161-6","article-title":"Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications","volume":"402","author":"D\u00e9glon","year":"2012","journal-title":"Anal Bioanal Chem."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"1631S","DOI":"10.1093\/jn\/131.5.1631S","article-title":"Use of filter paper for the collection and analysis of human whole blood specimens","volume":"131","author":"Mei","year":"2001","journal-title":"J Nutr."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.forsciint.2014.04.015","article-title":"Simplifying sample pretreatment: application of dried blood spot (DBS) method to blood samples, including postmortem, for UHPLC-MS\/MS analysis of drugs of abuse","volume":"243","author":"Odoardi","year":"2014","journal-title":"Forensic Sci Int."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jpba.2016.05.011","article-title":"Identification and quantification of psychoactive drugs in whole blood using dried blood spot (DBS) by ultra-performance liquid chromatography tandem mass spectrometry","volume":"128","author":"Kyriakou","year":"2016","journal-title":"J Pharm Biomed Anal."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.talanta.2014.11.052","article-title":"Chiral on-line solid phase extraction coupled to liquid chromatography-tandem mass spectrometry assay for quantification of (R) and (S) enantiomers of methadone and its main metabolite in plasma","volume":"134","author":"Bouquie","year":"2015","journal-title":"Talanta."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jat\/31.7.388","article-title":"Microwave-assisted extraction and HPLC-DAD determination of drugs of abuse in human plasma","volume":"31","author":"Fern\u00e1ndez","year":"2007","journal-title":"J Anal Toxicol."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.talanta.2015.11.044","article-title":"Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection","volume":"149","author":"George","year":"2016","journal-title":"Talanta."},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jchromb.2006.02.013","article-title":"Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and alprazolam in human plasma by liquid chromatography-electrospray ionization mass spectrometry","volume":"834","author":"Quintela","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.talanta.2012.03.004","article-title":"Preconcentration of trace amounts of methadone in human urine, plasma, saliva and sweat samples using dispersive liquid-liquid microextraction followed by high performance liquid chromatography","volume":"94","author":"Ranjbari","year":"2012","journal-title":"Talanta."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jchromb.2006.11.025","article-title":"Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography\/mass spectrometry","volume":"850","author":"Rodriguez-Rosas","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R29-20230814","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jchromb.2005.05.048","article-title":"The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry","volume":"824","author":"Rook","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"issue":"suppl 2","key":"R30-20230814","first-page":"130","article-title":"Stereoselective determination of methadone and its main metabolite in serum and urine from methadone maintenance patients","volume":"27","author":"Valentov\u00e1","year":"2006","journal-title":"Neuro Endocrinol Lett."},{"key":"R31-20230814","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchromb.2006.09.035","article-title":"Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes","volume":"847","author":"Mercolini","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R32-20230814","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jat\/32.7.499","article-title":"Chiral analysis of methadone and its main metabolite EDDP in postmortem blood by liquid chromatography-mass spectrometry","volume":"32","author":"Johansen","year":"2008","journal-title":"J Anal Toxicol."},{"key":"R37-20230814","first-page":"5455","article-title":"Method development in forensic toxicology","volume":"23","author":"Peters","year":"2017","journal-title":"Curr Pharm Des."},{"key":"R38-20230814","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1570-0232(02)00142-3","article-title":"Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries","volume":"773","author":"Muller","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R39-20230814","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.talanta.2014.10.040","article-title":"Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots\u2014development, validation and clinical application during breast cancer adjuvant therapy","volume":"132","author":"Antunes","year":"2015","journal-title":"Talanta."},{"key":"R40-20230814","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00216-011-4775-z","article-title":"A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry","volume":"400","author":"Clavijo","year":"2011","journal-title":"Anal Bioanal Chem."},{"key":"R41-20230814","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1002\/jssc.201100422","article-title":"A low blood volume LC-MS\/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children","volume":"34","author":"Clavijo","year":"2011","journal-title":"J Sep Sci."},{"key":"R42-20230814","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/petr.12392","article-title":"Tacrolimus and sirolimus in capillary dried blood spots allows for remote monitoring","volume":"19","author":"Dickerson","year":"2015","journal-title":"Pediatr Transplant."},{"key":"R43-20230814","doi-asserted-by":"crossref","first-page":"12112","DOI":"10.1021\/acs.analchem.5b03077","article-title":"Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertension","volume":"87","author":"Enderle","year":"2015","journal-title":"Anal Chem."},{"key":"R44-20230814","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4155\/bio.14.157","article-title":"Determination of tamoxifen and endoxifen in dried blood spots using LC-MS\/MS and the effect of coated DBS cards on recovery and matrix effects","volume":"6","author":"Jager","year":"2014","journal-title":"Bioanalysis."},{"key":"R45-20230814","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpba.2015.02.023","article-title":"Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC-MS\/MS methods","volume":"109","author":"Kostic","year":"2015","journal-title":"J Pharm Biomed Anal."},{"key":"R46-20230814","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4155\/bio.14.156","article-title":"Spot them in the spot: analysis of abused substances using dried blood spots","volume":"6","author":"Sadones","year":"2014","journal-title":"Bioanalysis."},{"key":"R47-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2013.04.007","article-title":"Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry","volume":"83","author":"Taylor","year":"2013","journal-title":"J Pharm Biomed Anal."},{"key":"R48-20230814","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1007\/s00216-012-6460-2","article-title":"Methadone concentrations in blood, plasma, and oral fluid determined by isotope-dilution gas chromatography-mass spectrometry","volume":"405","author":"Hsu","year":"2013","journal-title":"Anal Bioanal Chem."},{"key":"R49-20230814","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1373\/clinchem.2010.154864","article-title":"Maternal methadone dose, placental methadone concentrations, and neonatal outcomes","volume":"57","author":"de Castro","year":"2011","journal-title":"Clin Chem."},{"key":"R50-20230814","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.2000.00272.x","article-title":"Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients","volume":"50","author":"Foster","year":"2000","journal-title":"Br J Clin Pharmacol."},{"key":"R51-20230814","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1009935116877","article-title":"Drug levels: therapeutic and toxic serum\/plasma concentrations of common drugs","volume":"15","author":"Regenthal","year":"1999","journal-title":"J Clin Monit Comput."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:32:09Z","timestamp":1692052329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000674","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}